Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Ann M. Thomas"'
Autor:
Ann M. Thomas, Philip D. Poorvu, Elizabeth S. Ginsburg, Ann H. Partridge, Anna Greer, Andrea Lanes, Patricia Kennedy
Publikováno v:
Cancer. 127:3872-3880
Background Many young women with breast cancer undergo fertility preservation (FP) before cancer treatment. This study examined the impact of FP on breast cancer outcomes. Methods The authors performed a retrospective cohort study of 272 women aged 2
Publikováno v:
Fertility Research and Practice, Vol 6, Iss 1, Pp 1-6 (2020)
Fertility Research and Practice
Fertility Research and Practice
Background The optimal route of progesterone administration for luteal support in cryopreserved embryo transfer (CET) has been the subject of much debate. While most published research has pertained to day 3 transfers, recent data on blastocyst CET h
Autor:
Taylor Nordan, Patrick Y. Wen, Elizabeth S. Ginsburg, Andrey V. Dolinko, Pietro Bortoletto, Ann M. Thomas
Publikováno v:
Journal of Neuro-Oncology. 147:371-376
With advances in cancer therapy, reproductive-aged women can look forward to a life post-malignancy. Fortunately, fertility preservation (FP) may provide relief from potential infertility caused by cancer or associated caustic treatments. Outcomes of
Autor:
Phillip A. Romanski, Catherine Racowsky, Paula C. Brady, Daniela Carusi, Jennifer B. Bakkensen, Ann M. Thomas
Publikováno v:
J Assist Reprod Genet
PURPOSE: To assess the importance of each blastocyst morphological criteria with pregnancy and perinatal outcomes. METHODS: This single-center retrospective cohort study included blastocyst single embryo transfers (SET) performed between 1/2012–2/2
Autor:
Catherine Racowsky, Andrea Lanes, Ann M. Thomas, Emily R. Disler, Ian N. Waldman, Mark D. Hornstein
Publikováno v:
Fertility Research and Practice, Vol 7, Iss 1, Pp 1-7 (2021)
Fertility Research and Practice
Fertility Research and Practice
Background More than 67% of all embryos transferred in the United States involve frozen-thawed embryos. Progesterone supplementation is necessary in medicated cycles to luteinize the endometrium and prepare it for implantation, but little data is ava
Publikováno v:
Fertility Research and Practice
Fertility Research and Practice, Vol 7, Iss 1, Pp 1-8 (2021)
Fertility Research and Practice, Vol 7, Iss 1, Pp 1-8 (2021)
Background A number of studies have looked at dual triggers with hCG and GnRH agonist (GnRHa) in varying doses, but the question remains: what is the optimal dose of hCG to minimize ovarian hyperstimulation syndrome (OHSS) and still offer adequate pr
Publikováno v:
J Assist Reprod Genet
PURPOSE: To test whether an electronic whiteboard in the IVF laboratory increases the likelihood that critical evaluation procedures are performed within optimum pre-set time ranges. METHODS: A retrospective cohort study of oocyte retrievals in our I
Autor:
Guodong Li, Ann M Thomas, Jessica A Williams, Bo Kong, Jie Liu, Yuka Inaba, Wen Xie, Grace L Guo
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e35895 (2012)
Farnesoid X receptor (FXR) is a nuclear receptor and a key regulator of liver cholesterol and triglyceride homeostasis. Scavenger receptor class B type I (SR-BI) is critical for reverse cholesterol transport (RCT) by transporting high-density lipopro
Externí odkaz:
https://doaj.org/article/a70d978a0274447eb063b0e1ad5da4da
Autor:
Jessica A Williams, Ann M Thomas, Guodong Li, Bo Kong, Le Zhan, Yuka Inaba, Wen Xie, Wen-Xing Ding, Grace L Guo
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43961 (2012)
Farnesoid X Receptor (FXR) is a member of the nuclear receptor superfamily and is a ligand-activated transcription factor essential for maintaining liver and intestinal homeostasis. FXR is protective against carcinogenesis and inflammation in liver a
Externí odkaz:
https://doaj.org/article/7121c65697284a77b2dca56660946c0a
Autor:
Taylor, Nordan, Ann M, Thomas, Elizabeth S, Ginsburg, Patrick Y, Wen, Andrey V, Dolinko, Pietro, Bortoletto
Publikováno v:
Journal of neuro-oncology. 147(2)
With advances in cancer therapy, reproductive-aged women can look forward to a life post-malignancy. Fortunately, fertility preservation (FP) may provide relief from potential infertility caused by cancer or associated caustic treatments. Outcomes of